Page last updated: 2024-09-03
l 158809 and actinium
l 158809 has been researched along with actinium in 1 studies
Compound Research Comparison
| Studies (l 158809) | Trials (l 158809) | Recent Studies (post-2010) (l 158809) | Studies (actinium) | Trials (actinium) | Recent Studies (post-2010) (actinium) |
|---|---|---|---|---|---|
| 137 | 0 | 7 | 240 | 1 | 142 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hyjek, E; Jaggi, JS; McDevitt, MR; Scheinberg, DA; Seshan, SV; Sgouros, G | 1 |
Other Studies
1 other study(ies) available for l 158809 and actinium
| Article | Year |
|---|---|
Mitigation of radiation nephropathy after internal alpha-particle irradiation of kidneys.
Topics: Actinium; Alpha Particles; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Female; Imidazoles; Kidney; Kidney Tubules; Mice; Mice, Inbred BALB C; Mineralocorticoid Receptor Antagonists; Radiation Dosage; Radiation Injuries, Experimental; Radiation-Protective Agents; Random Allocation; Spironolactone; Tetrazoles | 2006 |